ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 1983-09-16
    Description: Cigarette smoking is the major risk factor for the development of pulmonary emphysema, a disorder that may result from an imbalance between the elastase and antielastase levels in the lungs. Decreased functional alpha 1-protease inhibitor, an inhibitor of neutrophil elastase, might render smokers susceptible to elastase-catalyzed destruction of pulmonary elastic fibers and the development of emphysema. Binding and inactivation of isotopically labeled porcine pancreatic elastase and human neutrophil elastase by alpha 1-protease inhibitor were measured in fluid obtained by bronchoalveolar lavage of volunteers. The inhibition of elastase-catalyzed solubilization of elastin and a tripeptide substrate were also determined. The mean level of functional alpha 1-protease inhibitor in the bronchoalveolar lavage fluid of smokers was found to be equal to or greater than that of nonsmokers, contradicting reports by other investigators. Increased elastase derived from pulmonary neutrophils, rather than decreased functional alpha 1-protease inhibitor, appears to be the main factor in the genesis of emphysema in smokers.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Stone, P J -- Calore, J D -- McGowan, S E -- Bernardo, J -- Snider, G L -- Franzblau, C -- HL-19717/HL/NHLBI NIH HHS/ -- HL-25229/HL/NHLBI NIH HHS/ -- New York, N.Y. -- Science. 1983 Sep 16;221(4616):1187-9.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6612333" target="_blank"〉PubMed〈/a〉
    Keywords: Adult ; Bronchi/*metabolism ; Female ; Humans ; In Vitro Techniques ; Male ; Neutrophils/metabolism ; Protease Inhibitors/*metabolism ; Pulmonary Alveoli/*metabolism ; *Smoking
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 1986-02-14
    Description: Ivermectin, given to onchocerciasis patients as a single oral dose of 200 micrograms per kilogram of body weight, substantially reduced the uptake of Onchocerca volvulus microfilariae by Simulium yahense, an efficient black fly vector of the parasite in the tropical rain forests of West Africa. Three months after treatment, patients given ivermectin infected flies at a significantly lower rate than those who had received diethylcarbamazine or placebo, thereby reducing the number of developing larvae in the vector population. This diminished rate of infectiousness was also evident 6 months after treatment. These results strongly suggest that ivermectin could be effective in interrupting transmission of Onchocerca volvulus for epidemiologically important periods of time.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Cupp, E W -- Bernardo, M J -- Kiszewski, A E -- Collins, R C -- Taylor, H R -- Aziz, M A -- Greene, B M -- New York, N.Y. -- Science. 1986 Feb 14;231(4739):740-2.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/3753801" target="_blank"〉PubMed〈/a〉
    Keywords: Humans ; Insect Vectors/parasitology ; Ivermectin ; Lactones/*therapeutic use ; Onchocerca/growth & development ; Onchocerciasis/drug therapy/*transmission ; Simuliidae/*parasitology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...